| 1 | tended | 3,809 |
| 2 | continues | 1,968 |
| 3 | tend | 1,235 |
| 4 | belonging | 1,170 |
| 5 | tends | 560 |
| 6 | belonged | 484 |
| 7 | belong | 466 |
| 8 | amounted | 250 |
| 9 | ought | 146 |
| 10 | wishing | 92 |
| 11 | tending | 69 |
| 12 | pertained | 48 |
| 13 | .due | 6 |
| 14 | -95.93 | 3 |
| 15 | caudodorsal | 3 |
| 16 | -129.48 | 2 |
| 17 | -18.10 | 2 |
| 18 | 1/2002 | 2 |
| 19 | acclimates | 2 |
| 20 | adults.due | 2 |
| 21 | opa≥8 | 2 |
| 22 | paleonura | 2 |
| 23 | tunnel-coupled | 2 |
| 24 | willingness/unwillingness | 2 |
| 25 | 'nothing | 1 |
| 26 | *16 | 1 |
| 27 | *20 | 1 |
| 28 | *51 | 1 |
| 29 | +12.09 | 1 |
| 30 | +12.96 | 1 |
| 31 | +17.67 | 1 |
| 32 | ,1947 | 1 |
| 33 | ,1966 | 1 |
| 34 | ,3-ε-2'-deoxyarabinoguanosine | 1 |
| 35 | -10.83 | 1 |
| 36 | -106.08 | 1 |
| 37 | -130.43 | 1 |
| 38 | -15.45 | 1 |
| 39 | -15.62 | 1 |
| 40 | -168.05 | 1 |
| 41 | -189.01 | 1 |
| 42 | -19.56 | 1 |
| 43 | -1h-pyrazole-4-carbaldehydes | 1 |
| 44 | -23.26 | 1 |
| 45 | -25.02 | 1 |
| 46 | -26.57 | 1 |
| 47 | -26.83 | 1 |
| 48 | -2613 | 1 |
| 49 | -28.22 | 1 |
| 50 | -28.57 | 1 |
| 51 | -29.93 | 1 |
| 52 | -2·09 | 1 |
| 53 | -3-hydroxy | 1 |
| 54 | -32.18 | 1 |
| 55 | -35.86 | 1 |
| 56 | -37.91 | 1 |
| 57 | -397.66 | 1 |
| 58 | -3·81 | 1 |
| 59 | -4-keto-6-deoxyglucose | 1 |
| 60 | -401.20 | 1 |
| 61 | -42.55 | 1 |
| 62 | -47.41 | 1 |
| 63 | -496.29 | 1 |
| 64 | -4·88 | 1 |
| 65 | -5.3° | 1 |
| 66 | -59.7 | 1 |
| 67 | -604 | 1 |
| 68 | -66.12 | 1 |
| 69 | -67.74 | 1 |
| 70 | -674 | 1 |
| 71 | -869.44 | 1 |
| 72 | -88.75 | 1 |
| 73 | -91.34 | 1 |
| 74 | -92.32 | 1 |
| 75 | -978 | 1 |
| 76 | -98.76 | 1 |
| 77 | -99.39 | 1 |
| 78 | -according | 1 |
| 79 | -anchor | 1 |
| 80 | -coupling | 1 |
| 81 | -identical | 1 |
| 82 | -mevalonate-5-diphosphate | 1 |
| 83 | -trehalose | 1 |
| 84 | .motivation | 1 |
| 85 | .up | 1 |
| 86 | /alum | 1 |
| 87 | /biologics | 1 |
| 88 | /camk-1 | 1 |
| 89 | /das28 | 1 |
| 90 | /lif/al | 1 |
| 91 | /platelet | 1 |
| 92 | 0-meridian | 1 |
| 93 | 0.182937 | 1 |
| 94 | 0.26±0.40 | 1 |
| 95 | 0.325-31.6 | 1 |
| 96 | 0.8134 | 1 |
| 97 | 0.8370 | 1 |
| 98 | 0.8919 | 1 |
| 99 | 0.9190 | 1 |
| 100 | 0.9674 | 1 |
| 101 | 0.9738 | 1 |
| 102 | 0.9778 | 1 |
| 103 | 0.9784 | 1 |
| 104 | 0.9946 | 1 |
| 105 | 1-3b | 1 |
| 106 | 1-beta-d-arabinofuranosulcytosine | 1 |
| 107 | 1.2038 | 1 |
| 108 | 1.80±0.2 | 1 |
| 109 | 1/erk2 | 1 |
| 110 | 101+/-25 | 1 |
| 111 | 104° | 1 |
| 112 | 108+/-22 | 1 |
| 113 | 110+/-26 | 1 |
| 114 | 119.19±1.71 | 1 |
| 115 | 12,163 | 1 |
| 116 | 12,359 | 1 |
| 117 | 12/31/2001 | 1 |
| 118 | 1200mg/kg | 1 |
| 119 | 121,220 | 1 |
| 120 | 142+/-43 | 1 |
| 121 | 142.2/78.3 | 1 |
| 122 | 144+/-69 | 1 |
| 123 | 15,998 | 1 |
| 124 | 16.8- | 1 |
| 125 | 163±7/87±8 | 1 |
| 126 | 166.72±64.26 | 1 |
| 127 | 16·9±6 | 1 |
| 128 | 198+/-37 | 1 |
| 129 | 1:160,000 | 1 |
| 130 | 2,3-dimethylbutadiene | 1 |
| 131 | 2-y-olds | 1 |
| 132 | 2-¹³c-glucose | 1 |
| 133 | 201+/-62 | 1 |
| 134 | 204.88±115.9 | 1 |
| 135 | 238.1±118.9 | 1 |
| 136 | 28.25±14.5 | 1 |
| 137 | 3-alkylthiooxindoles | 1 |
| 138 | 3-amino-4-iodopyridines | 1 |
| 139 | 328.0±4.6 | 1 |
| 140 | 37.2±16.9 | 1 |
| 141 | 43.2+/-13.6 | 1 |
| 142 | 48,578 | 1 |
| 143 | 5.4±2.1 | 1 |
| 144 | 554-555 | 1 |
| 145 | 556.5 | 1 |
| 146 | 6,990 | 1 |
| 147 | 61.0±6.1 | 1 |
| 148 | 66,791 | 1 |
| 149 | 67,207 | 1 |
| 150 | 677/2-1.1 | 1 |
| 151 | 67·9 | 1 |
| 152 | 69±31 | 1 |
| 153 | 7.3+/-0.8 | 1 |
| 154 | 71.8±22.9 | 1 |
| 155 | 73+/-33 | 1 |
| 156 | 77,456 | 1 |
| 157 | 7866 | 1 |
| 158 | 7907 | 1 |
| 159 | 831/2-1 | 1 |
| 160 | 8624 | 1 |
| 161 | 8639 | 1 |
| 162 | 8703 | 1 |
| 163 | 88.2±9.8 | 1 |
| 164 | 92±32 | 1 |
| 165 | 9558 | 1 |
| 166 | 99.19 | 1 |
| 167 | :1.51 | 1 |
| 168 | :1.55 | 1 |
| 169 | =-0.23 | 1 |
| 170 | =-0.59 | 1 |
| 171 | =-2.84 | 1 |
| 172 | =-21.89 | 1 |
| 173 | =-37.40 | 1 |
| 174 | =-6.42 | 1 |
| 175 | a/time | 1 |
| 176 | acquiesces | 1 |
| 177 | af-couple | 1 |
| 178 | amidations | 1 |
| 179 | antidepressants-0.17 | 1 |
| 180 | apx1/apx2 | 1 |
| 181 | arylsulfonohydrazides | 1 |
| 182 | assented | 1 |
| 183 | at/distal | 1 |
| 184 | b-measurements | 1 |
| 185 | beloning | 1 |
| 186 | benefi-cial | 1 |
| 187 | benefits/costs | 1 |
| 188 | benifits | 1 |
| 189 | bioglue® | 1 |
| 190 | biovin | 1 |
| 191 | c-aa | 1 |
| 192 | cadmium-metallothionein | 1 |
| 193 | can4.80 | 1 |
| 194 | cavernosography/cavernosometry | 1 |
| 195 | cohen-kappa | 1 |
| 196 | colwellia | 1 |
| 197 | community-employed | 1 |
| 198 | conformities | 1 |
| 199 | consom | 1 |
| 200 | convertion | 1 |
| 201 | cross-addiction | 1 |
| 202 | cytadhered | 1 |
| 203 | deacons | 1 |
| 204 | destinated | 1 |
| 205 | devices/procedures | 1 |
| 206 | discotheques | 1 |
| 207 | dishabituated | 1 |
| 208 | dry-etched | 1 |
| 209 | elects | 1 |
| 210 | endoscopy/histology | 1 |
| 211 | ethanol/lorazepam | 1 |
| 212 | euro15,634 | 1 |
| 213 | euro39,340 | 1 |
| 214 | f-naf-pet | 1 |
| 215 | ferritin.prior | 1 |
| 216 | fim-test | 1 |
| 217 | frutful | 1 |
| 218 | fuel-nitrogen | 1 |
| 219 | gender-standardization | 1 |
| 220 | gender-standardized | 1 |
| 221 | gsk-3/shaggy | 1 |
| 222 | half-shoes | 1 |
| 223 | high-/low-risks | 1 |
| 224 | hqsar | 1 |
| 225 | hyperaesthesia | 1 |
| 226 | hypnotherapists | 1 |
| 227 | i-bands | 1 |
| 228 | i-uii | 1 |
| 229 | iffmc | 1 |
| 230 | iga-up | 1 |
| 231 | immnunoflurescene | 1 |
| 232 | incerti | 1 |
| 233 | initiator/catalyst | 1 |
| 234 | intermediate/resistant | 1 |
| 235 | irresponsiveness | 1 |
| 236 | iv-viii | 1 |
| 237 | joysticks | 1 |
| 238 | kedougou | 1 |
| 239 | length-polymorphisms | 1 |
| 240 | lrrtm2 | 1 |
| 241 | lycodichthys | 1 |
| 242 | m91.1 | 1 |
| 243 | massilia | 1 |
| 244 | mazama | 1 |
| 245 | merchandising | 1 |
| 246 | meso-lactide | 1 |
| 247 | motivation/confidence | 1 |
| 248 | mudflats | 1 |
| 249 | nife-hydrogenase | 1 |
| 250 | non-applicable | 1 |
| 251 | non-generalizability | 1 |
| 252 | non-nitrogen-fixing | 1 |
| 253 | non-responses | 1 |
| 254 | non-sclcs | 1 |
| 255 | non-subjected | 1 |
| 256 | not-responding | 1 |
| 257 | octasaccharide | 1 |
| 258 | ofuropathogens | 1 |
| 259 | or-contrary | 1 |
| 260 | oxycarbamate | 1 |
| 261 | p2x-receptors | 1 |
| 262 | p73alpha | 1 |
| 263 | pamam-rrrk | 1 |
| 264 | pander | 1 |
| 265 | parmelina | 1 |
| 266 | pbto2- | 1 |
| 267 | pc=-0.73 | 1 |
| 268 | pc=-1.30 | 1 |
| 269 | per-residue | 1 |
| 270 | persistence/loss | 1 |
| 271 | photobleached | 1 |
| 272 | picnics | 1 |
| 273 | picochlorum | 1 |
| 274 | post-24- | 1 |
| 275 | postpresentation | 1 |
| 276 | pound3655 | 1 |
| 277 | ppuz | 1 |
| 278 | pre-beta-lipoproteins | 1 |
| 279 | prewithdrawal | 1 |
| 280 | prophylaxis/therapy | 1 |
| 281 | ptcl2/co | 1 |
| 282 | ralb | 1 |
| 283 | randomized-12 | 1 |
| 284 | re-referral | 1 |
| 285 | recovered/adapted | 1 |
| 286 | recut | 1 |
| 287 | reflex-appears | 1 |
| 288 | refolds | 1 |
| 289 | relatives/carers | 1 |
| 290 | reradiate | 1 |
| 291 | respread | 1 |
| 292 | retention-effect | 1 |
| 293 | seconder | 1 |
| 294 | self-adaptation | 1 |
| 295 | ser44 | 1 |
| 296 | serranus | 1 |
| 297 | shc/n-shc | 1 |
| 298 | strumigenys | 1 |
| 299 | sulfenates | 1 |
| 300 | support-building | 1 |
| 301 | sxm-2 | 1 |
| 302 | syn-5 | 1 |
| 303 | targeted-deep-sequencing | 1 |
| 304 | temperaturesforpulpitis | 1 |
| 305 | tibetan-adhering | 1 |
| 306 | tmsi | 1 |
| 307 | tonsilectomy | 1 |
| 308 | torturous | 1 |
| 309 | transformatively | 1 |
| 310 | treatment.according | 1 |
| 311 | tyr451 | 1 |
| 312 | unrelatable | 1 |
| 313 | vertexed | 1 |
| 314 | xanthoria | 1 |
| 315 | z-bp | 1 |
| 316 | ~10.7 | 1 |
| 317 | ~256 | 1 |
| 318 | £39,657 | 1 |
| 319 | £6 | 1 |
| 320 | αseem | 1 |
| 321 | φsp-3 | 1 |
| 322 | €24,900 | 1 |
| 323 | €5484 | 1 |
| 324 | −7.76 | 1 |
| 325 | −8.27 | 1 |
| 326 | √1 | 1 |
| 327 | ≥150/μl | 1 |
| 328 | ≥4.8 | 1 |
| 1 | 'nothing | 1 |
| 2 | *16 | 1 |
| 3 | *20 | 1 |
| 4 | *51 | 1 |
| 5 | +12.09 | 1 |
| 6 | +12.96 | 1 |
| 7 | +17.67 | 1 |
| 8 | ,1947 | 1 |
| 9 | ,1966 | 1 |
| 10 | ,3-ε-2'-deoxyarabinoguanosine | 1 |
| 11 | -10.83 | 1 |
| 12 | -106.08 | 1 |
| 13 | -129.48 | 2 |
| 14 | -130.43 | 1 |
| 15 | -15.45 | 1 |
| 16 | -15.62 | 1 |
| 17 | -168.05 | 1 |
| 18 | -18.10 | 2 |
| 19 | -189.01 | 1 |
| 20 | -19.56 | 1 |
| 21 | -1h-pyrazole-4-carbaldehydes | 1 |
| 22 | -23.26 | 1 |
| 23 | -25.02 | 1 |
| 24 | -26.57 | 1 |
| 25 | -26.83 | 1 |
| 26 | -2613 | 1 |
| 27 | -28.22 | 1 |
| 28 | -28.57 | 1 |
| 29 | -29.93 | 1 |
| 30 | -2·09 | 1 |
| 31 | -3-hydroxy | 1 |
| 32 | -32.18 | 1 |
| 33 | -35.86 | 1 |
| 34 | -37.91 | 1 |
| 35 | -397.66 | 1 |
| 36 | -3·81 | 1 |
| 37 | -4-keto-6-deoxyglucose | 1 |
| 38 | -401.20 | 1 |
| 39 | -42.55 | 1 |
| 40 | -47.41 | 1 |
| 41 | -496.29 | 1 |
| 42 | -4·88 | 1 |
| 43 | -5.3° | 1 |
| 44 | -59.7 | 1 |
| 45 | -604 | 1 |
| 46 | -66.12 | 1 |
| 47 | -67.74 | 1 |
| 48 | -674 | 1 |
| 49 | -869.44 | 1 |
| 50 | -88.75 | 1 |
| 51 | -91.34 | 1 |
| 52 | -92.32 | 1 |
| 53 | -95.93 | 3 |
| 54 | -978 | 1 |
| 55 | -98.76 | 1 |
| 56 | -99.39 | 1 |
| 57 | -according | 1 |
| 58 | -anchor | 1 |
| 59 | -coupling | 1 |
| 60 | -identical | 1 |
| 61 | -mevalonate-5-diphosphate | 1 |
| 62 | -trehalose | 1 |
| 63 | .due | 6 |
| 64 | .motivation | 1 |
| 65 | .up | 1 |
| 66 | /alum | 1 |
| 67 | /biologics | 1 |
| 68 | /camk-1 | 1 |
| 69 | /das28 | 1 |
| 70 | /lif/al | 1 |
| 71 | /platelet | 1 |
| 72 | 0-meridian | 1 |
| 73 | 0.182937 | 1 |
| 74 | 0.26±0.40 | 1 |
| 75 | 0.325-31.6 | 1 |
| 76 | 0.8134 | 1 |
| 77 | 0.8370 | 1 |
| 78 | 0.8919 | 1 |
| 79 | 0.9190 | 1 |
| 80 | 0.9674 | 1 |
| 81 | 0.9738 | 1 |
| 82 | 0.9778 | 1 |
| 83 | 0.9784 | 1 |
| 84 | 0.9946 | 1 |
| 85 | 1-3b | 1 |
| 86 | 1-beta-d-arabinofuranosulcytosine | 1 |
| 87 | 1.2038 | 1 |
| 88 | 1.80±0.2 | 1 |
| 89 | 1/2002 | 2 |
| 90 | 1/erk2 | 1 |
| 91 | 101+/-25 | 1 |
| 92 | 104° | 1 |
| 93 | 108+/-22 | 1 |
| 94 | 110+/-26 | 1 |
| 95 | 119.19±1.71 | 1 |
| 96 | 12,163 | 1 |
| 97 | 12,359 | 1 |
| 98 | 12/31/2001 | 1 |
| 99 | 1200mg/kg | 1 |
| 100 | 121,220 | 1 |
| 101 | 142+/-43 | 1 |
| 102 | 142.2/78.3 | 1 |
| 103 | 144+/-69 | 1 |
| 104 | 15,998 | 1 |
| 105 | 16.8- | 1 |
| 106 | 163±7/87±8 | 1 |
| 107 | 166.72±64.26 | 1 |
| 108 | 16·9±6 | 1 |
| 109 | 198+/-37 | 1 |
| 110 | 1:160,000 | 1 |
| 111 | 2,3-dimethylbutadiene | 1 |
| 112 | 2-y-olds | 1 |
| 113 | 2-¹³c-glucose | 1 |
| 114 | 201+/-62 | 1 |
| 115 | 204.88±115.9 | 1 |
| 116 | 238.1±118.9 | 1 |
| 117 | 28.25±14.5 | 1 |
| 118 | 3-alkylthiooxindoles | 1 |
| 119 | 3-amino-4-iodopyridines | 1 |
| 120 | 328.0±4.6 | 1 |
| 121 | 37.2±16.9 | 1 |
| 122 | 43.2+/-13.6 | 1 |
| 123 | 48,578 | 1 |
| 124 | 5.4±2.1 | 1 |
| 125 | 554-555 | 1 |
| 126 | 556.5 | 1 |
| 127 | 6,990 | 1 |
| 128 | 61.0±6.1 | 1 |
| 129 | 66,791 | 1 |
| 130 | 67,207 | 1 |
| 131 | 677/2-1.1 | 1 |
| 132 | 67·9 | 1 |
| 133 | 69±31 | 1 |
| 134 | 7.3+/-0.8 | 1 |
| 135 | 71.8±22.9 | 1 |
| 136 | 73+/-33 | 1 |
| 137 | 77,456 | 1 |
| 138 | 7866 | 1 |
| 139 | 7907 | 1 |
| 140 | 831/2-1 | 1 |
| 141 | 8624 | 1 |
| 142 | 8639 | 1 |
| 143 | 8703 | 1 |
| 144 | 88.2±9.8 | 1 |
| 145 | 92±32 | 1 |
| 146 | 9558 | 1 |
| 147 | 99.19 | 1 |
| 148 | :1.51 | 1 |
| 149 | :1.55 | 1 |
| 150 | =-0.23 | 1 |
| 151 | =-0.59 | 1 |
| 152 | =-2.84 | 1 |
| 153 | =-21.89 | 1 |
| 154 | =-37.40 | 1 |
| 155 | =-6.42 | 1 |
| 156 | a/time | 1 |
| 157 | acclimates | 2 |
| 158 | acquiesces | 1 |
| 159 | adults.due | 2 |
| 160 | af-couple | 1 |
| 161 | amidations | 1 |
| 162 | amounted | 250 |
| 163 | antidepressants-0.17 | 1 |
| 164 | apx1/apx2 | 1 |
| 165 | arylsulfonohydrazides | 1 |
| 166 | assented | 1 |
| 167 | at/distal | 1 |
| 168 | b-measurements | 1 |
| 169 | belong | 466 |
| 170 | belonged | 484 |
| 171 | belonging | 1,170 |
| 172 | beloning | 1 |
| 173 | benefi-cial | 1 |
| 174 | benefits/costs | 1 |
| 175 | benifits | 1 |
| 176 | bioglue® | 1 |
| 177 | biovin | 1 |
| 178 | c-aa | 1 |
| 179 | cadmium-metallothionein | 1 |
| 180 | can4.80 | 1 |
| 181 | caudodorsal | 3 |
| 182 | cavernosography/cavernosometry | 1 |
| 183 | cohen-kappa | 1 |
| 184 | colwellia | 1 |
| 185 | community-employed | 1 |
| 186 | conformities | 1 |
| 187 | consom | 1 |
| 188 | continues | 1,968 |
| 189 | convertion | 1 |
| 190 | cross-addiction | 1 |
| 191 | cytadhered | 1 |
| 192 | deacons | 1 |
| 193 | destinated | 1 |
| 194 | devices/procedures | 1 |
| 195 | discotheques | 1 |
| 196 | dishabituated | 1 |
| 197 | dry-etched | 1 |
| 198 | elects | 1 |
| 199 | endoscopy/histology | 1 |
| 200 | ethanol/lorazepam | 1 |
| 201 | euro15,634 | 1 |
| 202 | euro39,340 | 1 |
| 203 | f-naf-pet | 1 |
| 204 | ferritin.prior | 1 |
| 205 | fim-test | 1 |
| 206 | frutful | 1 |
| 207 | fuel-nitrogen | 1 |
| 208 | gender-standardization | 1 |
| 209 | gender-standardized | 1 |
| 210 | gsk-3/shaggy | 1 |
| 211 | half-shoes | 1 |
| 212 | high-/low-risks | 1 |
| 213 | hqsar | 1 |
| 214 | hyperaesthesia | 1 |
| 215 | hypnotherapists | 1 |
| 216 | i-bands | 1 |
| 217 | i-uii | 1 |
| 218 | iffmc | 1 |
| 219 | iga-up | 1 |
| 220 | immnunoflurescene | 1 |
| 221 | incerti | 1 |
| 222 | initiator/catalyst | 1 |
| 223 | intermediate/resistant | 1 |
| 224 | irresponsiveness | 1 |
| 225 | iv-viii | 1 |
| 226 | joysticks | 1 |
| 227 | kedougou | 1 |
| 228 | length-polymorphisms | 1 |
| 229 | lrrtm2 | 1 |
| 230 | lycodichthys | 1 |
| 231 | m91.1 | 1 |
| 232 | massilia | 1 |
| 233 | mazama | 1 |
| 234 | merchandising | 1 |
| 235 | meso-lactide | 1 |
| 236 | motivation/confidence | 1 |
| 237 | mudflats | 1 |
| 238 | nife-hydrogenase | 1 |
| 239 | non-applicable | 1 |
| 240 | non-generalizability | 1 |
| 241 | non-nitrogen-fixing | 1 |
| 242 | non-responses | 1 |
| 243 | non-sclcs | 1 |
| 244 | non-subjected | 1 |
| 245 | not-responding | 1 |
| 246 | octasaccharide | 1 |
| 247 | ofuropathogens | 1 |
| 248 | opa≥8 | 2 |
| 249 | or-contrary | 1 |
| 250 | ought | 146 |
| 251 | oxycarbamate | 1 |
| 252 | p2x-receptors | 1 |
| 253 | p73alpha | 1 |
| 254 | paleonura | 2 |
| 255 | pamam-rrrk | 1 |
| 256 | pander | 1 |
| 257 | parmelina | 1 |
| 258 | pbto2- | 1 |
| 259 | pc=-0.73 | 1 |
| 260 | pc=-1.30 | 1 |
| 261 | per-residue | 1 |
| 262 | persistence/loss | 1 |
| 263 | pertained | 48 |
| 264 | photobleached | 1 |
| 265 | picnics | 1 |
| 266 | picochlorum | 1 |
| 267 | post-24- | 1 |
| 268 | postpresentation | 1 |
| 269 | pound3655 | 1 |
| 270 | ppuz | 1 |
| 271 | pre-beta-lipoproteins | 1 |
| 272 | prewithdrawal | 1 |
| 273 | prophylaxis/therapy | 1 |
| 274 | ptcl2/co | 1 |
| 275 | ralb | 1 |
| 276 | randomized-12 | 1 |
| 277 | re-referral | 1 |
| 278 | recovered/adapted | 1 |
| 279 | recut | 1 |
| 280 | reflex-appears | 1 |
| 281 | refolds | 1 |
| 282 | relatives/carers | 1 |
| 283 | reradiate | 1 |
| 284 | respread | 1 |
| 285 | retention-effect | 1 |
| 286 | seconder | 1 |
| 287 | self-adaptation | 1 |
| 288 | ser44 | 1 |
| 289 | serranus | 1 |
| 290 | shc/n-shc | 1 |
| 291 | strumigenys | 1 |
| 292 | sulfenates | 1 |
| 293 | support-building | 1 |
| 294 | sxm-2 | 1 |
| 295 | syn-5 | 1 |
| 296 | targeted-deep-sequencing | 1 |
| 297 | temperaturesforpulpitis | 1 |
| 298 | tend | 1,235 |
| 299 | tended | 3,809 |
| 300 | tending | 69 |
| 301 | tends | 560 |
| 302 | tibetan-adhering | 1 |
| 303 | tmsi | 1 |
| 304 | tonsilectomy | 1 |
| 305 | torturous | 1 |
| 306 | transformatively | 1 |
| 307 | treatment.according | 1 |
| 308 | tunnel-coupled | 2 |
| 309 | tyr451 | 1 |
| 310 | unrelatable | 1 |
| 311 | vertexed | 1 |
| 312 | willingness/unwillingness | 2 |
| 313 | wishing | 92 |
| 314 | xanthoria | 1 |
| 315 | z-bp | 1 |
| 316 | ~10.7 | 1 |
| 317 | ~256 | 1 |
| 318 | £39,657 | 1 |
| 319 | £6 | 1 |
| 320 | αseem | 1 |
| 321 | φsp-3 | 1 |
| 322 | €24,900 | 1 |
| 323 | €5484 | 1 |
| 324 | −7.76 | 1 |
| 325 | −8.27 | 1 |
| 326 | √1 | 1 |
| 327 | ≥150/μl | 1 |
| 328 | ≥4.8 | 1 |
| 1 | pbto2- | 1 |
| 2 | post-24- | 1 |
| 3 | 16.8- | 1 |
| 4 | 1:160,000 | 1 |
| 5 | €24,900 | 1 |
| 6 | -18.10 | 2 |
| 7 | *20 | 1 |
| 8 | -401.20 | 1 |
| 9 | 121,220 | 1 |
| 10 | pc=-1.30 | 1 |
| 11 | 0.26±0.40 | 1 |
| 12 | =-37.40 | 1 |
| 13 | euro39,340 | 1 |
| 14 | 0.8370 | 1 |
| 15 | can4.80 | 1 |
| 16 | 0.9190 | 1 |
| 17 | 6,990 | 1 |
| 18 | 831/2-1 | 1 |
| 19 | /camk-1 | 1 |
| 20 | 677/2-1.1 | 1 |
| 21 | m91.1 | 1 |
| 22 | 5.4±2.1 | 1 |
| 23 | 61.0±6.1 | 1 |
| 24 | -189.01 | 1 |
| 25 | 12/31/2001 | 1 |
| 26 | 69±31 | 1 |
| 27 | -47.41 | 1 |
| 28 | *51 | 1 |
| 29 | :1.51 | 1 |
| 30 | tyr451 | 1 |
| 31 | 119.19±1.71 | 1 |
| 32 | -3·81 | 1 |
| 33 | -37.91 | 1 |
| 34 | 66,791 | 1 |
| 35 | √1 | 1 |
| 36 | sxm-2 | 1 |
| 37 | 1.80±0.2 | 1 |
| 38 | -25.02 | 1 |
| 39 | 1/2002 | 2 |
| 40 | randomized-12 | 1 |
| 41 | -66.12 | 1 |
| 42 | 108+/-22 | 1 |
| 43 | -28.22 | 1 |
| 44 | -92.32 | 1 |
| 45 | 92±32 | 1 |
| 46 | =-6.42 | 1 |
| 47 | 201+/-62 | 1 |
| 48 | -15.62 | 1 |
| 49 | 1/erk2 | 1 |
| 50 | lrrtm2 | 1 |
| 51 | apx1/apx2 | 1 |
| 52 | φsp-3 | 1 |
| 53 | 142.2/78.3 | 1 |
| 54 | 8703 | 1 |
| 55 | -2613 | 1 |
| 56 | =-0.23 | 1 |
| 57 | 73+/-33 | 1 |
| 58 | 142+/-43 | 1 |
| 59 | -130.43 | 1 |
| 60 | 12,163 | 1 |
| 61 | pc=-0.73 | 1 |
| 62 | -10.83 | 1 |
| 63 | -26.83 | 1 |
| 64 | -95.93 | 3 |
| 65 | -29.93 | 1 |
| 66 | -604 | 1 |
| 67 | 8624 | 1 |
| 68 | -91.34 | 1 |
| 69 | 0.8134 | 1 |
| 70 | euro15,634 | 1 |
| 71 | -869.44 | 1 |
| 72 | ser44 | 1 |
| 73 | -67.74 | 1 |
| 74 | -674 | 1 |
| 75 | 0.9674 | 1 |
| 76 | =-2.84 | 1 |
| 77 | €5484 | 1 |
| 78 | 0.9784 | 1 |
| 79 | syn-5 | 1 |
| 80 | 28.25±14.5 | 1 |
| 81 | 556.5 | 1 |
| 82 | -168.05 | 1 |
| 83 | 101+/-25 | 1 |
| 84 | -15.45 | 1 |
| 85 | :1.55 | 1 |
| 86 | -42.55 | 1 |
| 87 | 554-555 | 1 |
| 88 | pound3655 | 1 |
| 89 | -88.75 | 1 |
| 90 | 0.325-31.6 | 1 |
| 91 | 43.2+/-13.6 | 1 |
| 92 | 328.0±4.6 | 1 |
| 93 | *16 | 1 |
| 94 | 110+/-26 | 1 |
| 95 | -23.26 | 1 |
| 96 | 166.72±64.26 | 1 |
| 97 | 0.9946 | 1 |
| 98 | -19.56 | 1 |
| 99 | ~256 | 1 |
| 100 | 77,456 | 1 |
| 101 | -397.66 | 1 |
| 102 | 7866 | 1 |
| 103 | ,1966 | 1 |
| 104 | −7.76 | 1 |
| 105 | -98.76 | 1 |
| 106 | -35.86 | 1 |
| 107 | +12.96 | 1 |
| 108 | £6 | 1 |
| 109 | 16·9±6 | 1 |
| 110 | ~10.7 | 1 |
| 111 | -59.7 | 1 |
| 112 | 67,207 | 1 |
| 113 | 7907 | 1 |
| 114 | antidepressants-0.17 | 1 |
| 115 | −8.27 | 1 |
| 116 | 198+/-37 | 1 |
| 117 | 0.182937 | 1 |
| 118 | ,1947 | 1 |
| 119 | -26.57 | 1 |
| 120 | -28.57 | 1 |
| 121 | £39,657 | 1 |
| 122 | +17.67 | 1 |
| 123 | 7.3+/-0.8 | 1 |
| 124 | ≥4.8 | 1 |
| 125 | 88.2±9.8 | 1 |
| 126 | -106.08 | 1 |
| 127 | -32.18 | 1 |
| 128 | /das28 | 1 |
| 129 | 1.2038 | 1 |
| 130 | 0.9738 | 1 |
| 131 | -129.48 | 2 |
| 132 | 9558 | 1 |
| 133 | 48,578 | 1 |
| 134 | 0.9778 | 1 |
| 135 | -978 | 1 |
| 136 | -4·88 | 1 |
| 137 | 15,998 | 1 |
| 138 | opa≥8 | 2 |
| 139 | 163±7/87±8 | 1 |
| 140 | 71.8±22.9 | 1 |
| 141 | 204.88±115.9 | 1 |
| 142 | 37.2±16.9 | 1 |
| 143 | 238.1±118.9 | 1 |
| 144 | +12.09 | 1 |
| 145 | -2·09 | 1 |
| 146 | 99.19 | 1 |
| 147 | 0.8919 | 1 |
| 148 | -496.29 | 1 |
| 149 | -99.39 | 1 |
| 150 | 8639 | 1 |
| 151 | =-0.59 | 1 |
| 152 | 12,359 | 1 |
| 153 | 144+/-69 | 1 |
| 154 | =-21.89 | 1 |
| 155 | 67·9 | 1 |
| 156 | c-aa | 1 |
| 157 | p73alpha | 1 |
| 158 | massilia | 1 |
| 159 | colwellia | 1 |
| 160 | xanthoria | 1 |
| 161 | hyperaesthesia | 1 |
| 162 | mazama | 1 |
| 163 | parmelina | 1 |
| 164 | cohen-kappa | 1 |
| 165 | paleonura | 2 |
| 166 | 1-3b | 1 |
| 167 | ralb | 1 |
| 168 | shc/n-shc | 1 |
| 169 | iffmc | 1 |
| 170 | respread | 1 |
| 171 | tended | 3,809 |
| 172 | belonged | 484 |
| 173 | photobleached | 1 |
| 174 | dry-etched | 1 |
| 175 | tunnel-coupled | 2 |
| 176 | pertained | 48 |
| 177 | cytadhered | 1 |
| 178 | destinated | 1 |
| 179 | dishabituated | 1 |
| 180 | non-subjected | 1 |
| 181 | assented | 1 |
| 182 | amounted | 250 |
| 183 | recovered/adapted | 1 |
| 184 | vertexed | 1 |
| 185 | community-employed | 1 |
| 186 | gender-standardized | 1 |
| 187 | tend | 1,235 |
| 188 | motivation/confidence | 1 |
| 189 | octasaccharide | 1 |
| 190 | meso-lactide | 1 |
| 191 | non-applicable | 1 |
| 192 | unrelatable | 1 |
| 193 | af-couple | 1 |
| 194 | a/time | 1 |
| 195 | immnunoflurescene | 1 |
| 196 | 2,3-dimethylbutadiene | 1 |
| 197 | ,3-ε-2'-deoxyarabinoguanosine | 1 |
| 198 | 1-beta-d-arabinofuranosulcytosine | 1 |
| 199 | nife-hydrogenase | 1 |
| 200 | 2-¹³c-glucose | 1 |
| 201 | -4-keto-6-deoxyglucose | 1 |
| 202 | -trehalose | 1 |
| 203 | -mevalonate-5-diphosphate | 1 |
| 204 | reradiate | 1 |
| 205 | oxycarbamate | 1 |
| 206 | .due | 6 |
| 207 | adults.due | 2 |
| 208 | per-residue | 1 |
| 209 | 1200mg/kg | 1 |
| 210 | targeted-deep-sequencing | 1 |
| 211 | support-building | 1 |
| 212 | tending | 69 |
| 213 | not-responding | 1 |
| 214 | -according | 1 |
| 215 | treatment.according | 1 |
| 216 | belonging | 1,170 |
| 217 | wishing | 92 |
| 218 | 'nothing | 1 |
| 219 | -coupling | 1 |
| 220 | beloning | 1 |
| 221 | tibetan-adhering | 1 |
| 222 | merchandising | 1 |
| 223 | non-nitrogen-fixing | 1 |
| 224 | belong | 466 |
| 225 | iv-viii | 1 |
| 226 | i-uii | 1 |
| 227 | tmsi | 1 |
| 228 | incerti | 1 |
| 229 | pamam-rrrk | 1 |
| 230 | /lif/al | 1 |
| 231 | -identical | 1 |
| 232 | benefi-cial | 1 |
| 233 | re-referral | 1 |
| 234 | caudodorsal | 3 |
| 235 | at/distal | 1 |
| 236 | prewithdrawal | 1 |
| 237 | frutful | 1 |
| 238 | ≥150/μl | 1 |
| 239 | ethanol/lorazepam | 1 |
| 240 | αseem | 1 |
| 241 | consom | 1 |
| 242 | /alum | 1 |
| 243 | picochlorum | 1 |
| 244 | 0-meridian | 1 |
| 245 | fuel-nitrogen | 1 |
| 246 | cadmium-metallothionein | 1 |
| 247 | biovin | 1 |
| 248 | postpresentation | 1 |
| 249 | self-adaptation | 1 |
| 250 | .motivation | 1 |
| 251 | gender-standardization | 1 |
| 252 | cross-addiction | 1 |
| 253 | convertion | 1 |
| 254 | ptcl2/co | 1 |
| 255 | z-bp | 1 |
| 256 | iga-up | 1 |
| 257 | .up | 1 |
| 258 | hqsar | 1 |
| 259 | pander | 1 |
| 260 | seconder | 1 |
| 261 | -anchor | 1 |
| 262 | ferritin.prior | 1 |
| 263 | /biologics | 1 |
| 264 | picnics | 1 |
| 265 | non-sclcs | 1 |
| 266 | 2-y-olds | 1 |
| 267 | refolds | 1 |
| 268 | i-bands | 1 |
| 269 | tends | 560 |
| 270 | acquiesces | 1 |
| 271 | arylsulfonohydrazides | 1 |
| 272 | -1h-pyrazole-4-carbaldehydes | 1 |
| 273 | conformities | 1 |
| 274 | 3-alkylthiooxindoles | 1 |
| 275 | 3-amino-4-iodopyridines | 1 |
| 276 | half-shoes | 1 |
| 277 | devices/procedures | 1 |
| 278 | non-responses | 1 |
| 279 | acclimates | 2 |
| 280 | sulfenates | 1 |
| 281 | continues | 1,968 |
| 282 | discotheques | 1 |
| 283 | temperaturesforpulpitis | 1 |
| 284 | joysticks | 1 |
| 285 | high-/low-risks | 1 |
| 286 | length-polymorphisms | 1 |
| 287 | ofuropathogens | 1 |
| 288 | pre-beta-lipoproteins | 1 |
| 289 | deacons | 1 |
| 290 | amidations | 1 |
| 291 | reflex-appears | 1 |
| 292 | relatives/carers | 1 |
| 293 | p2x-receptors | 1 |
| 294 | irresponsiveness | 1 |
| 295 | willingness/unwillingness | 2 |
| 296 | persistence/loss | 1 |
| 297 | mudflats | 1 |
| 298 | elects | 1 |
| 299 | benifits | 1 |
| 300 | b-measurements | 1 |
| 301 | hypnotherapists | 1 |
| 302 | benefits/costs | 1 |
| 303 | serranus | 1 |
| 304 | torturous | 1 |
| 305 | lycodichthys | 1 |
| 306 | strumigenys | 1 |
| 307 | retention-effect | 1 |
| 308 | /platelet | 1 |
| 309 | f-naf-pet | 1 |
| 310 | ought | 146 |
| 311 | intermediate/resistant | 1 |
| 312 | fim-test | 1 |
| 313 | initiator/catalyst | 1 |
| 314 | recut | 1 |
| 315 | kedougou | 1 |
| 316 | gsk-3/shaggy | 1 |
| 317 | endoscopy/histology | 1 |
| 318 | transformatively | 1 |
| 319 | tonsilectomy | 1 |
| 320 | prophylaxis/therapy | 1 |
| 321 | or-contrary | 1 |
| 322 | cavernosography/cavernosometry | 1 |
| 323 | non-generalizability | 1 |
| 324 | -3-hydroxy | 1 |
| 325 | ppuz | 1 |
| 326 | bioglue® | 1 |
| 327 | -5.3° | 1 |
| 328 | 104° | 1 |